143 related articles for article (PubMed ID: 18864234)
1. Medical shock and death following neoarsphenamine therapy for syphilis.
KANEE B; ELLIOT GR
Can Med Assoc J; 1948 Jul; 59(1):28-32. PubMed ID: 18864234
[No Abstract] [Full Text] [Related]
2. [On the existence of Neosalvarsan].
Clemmesen J
Ugeskr Laeger; 1993 May; 155(21):1651-2. PubMed ID: 8317006
[No Abstract] [Full Text] [Related]
3. [Arsenical polyneuropathy. Report of two cases (author's transl)].
Tabuchi Y; Ogino J; Takahashi K; Yazima K; Tanabe H
Rinsho Shinkeigaku; 1981 Feb; 21(2):165-71. PubMed ID: 6266729
[No Abstract] [Full Text] [Related]
4. [Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature].
Salgado M; Sans M; Forns X; Bruguera M; Castells A; Navasa M; Rodés J
Gastroenterol Hepatol; 1995 Mar; 18(3):132-5. PubMed ID: 7621289
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic obstructive jaundice due to neoarsphenamine; ineffectiveness of therapy.
HARTMANN FL; SINGER AG
Arch Derm Syphilol; 1946 Jun; 53():620-4. PubMed ID: 20987149
[No Abstract] [Full Text] [Related]
6. The magic bullet hits many targets: Salvarsan's impact on UK health systems, 1909-1943.
Gelpi A; Tucker JD
Sex Transm Infect; 2015 Feb; 91(1):69-70. PubMed ID: 25609468
[No Abstract] [Full Text] [Related]
7. Renal damage resulting from idiosyncrasy to neoarsphenamine.
ANDERSON RH
Am J Med; 1947 Jan; 2(1):121-5. PubMed ID: 20278457
[No Abstract] [Full Text] [Related]
8. Introduction of salvarsan: (Paul Ehrlich).
Kampmeier RH
Sex Transm Dis; 1977; 4(2):66-8. PubMed ID: 333627
[No Abstract] [Full Text] [Related]
9. [Results obtained in the treatment of early syphilis employing long-term combined methods. I. Bismuth-neoarsphenamine].
CARRERA JL
Sem Med; 1955 Apr; 106(15):430-6. PubMed ID: 14385967
[No Abstract] [Full Text] [Related]
10. [Ehrlich and the "magic bullet" concept].
Calvo A
Rev Esp Quimioter; 2006 Mar; 19(1):90-2. PubMed ID: 16688302
[No Abstract] [Full Text] [Related]
11. [New fatal case of severe arsenical apoplexy].
LAUGIER P
Ann Dermatol Syphiligr (Paris); 1947 Apr; 7(4):146. PubMed ID: 20257211
[No Abstract] [Full Text] [Related]
12. [The Salvarsantod in the office hours; contributions to pathology and pathogenesis].
TASCHEN B
Dtsch Gesundheitsw; 1948 Feb; 3(3):74-6. PubMed ID: 18859618
[No Abstract] [Full Text] [Related]
13. [The problem of salvarsan allergy].
LAUSECKER H
Dermatol Wochenschr; 1955; 132(32):841-4. PubMed ID: 13250903
[No Abstract] [Full Text] [Related]
14. Paul Ehrlich: pioneer of chemotherapy and cure by arsenic (1854-1915).
Thorburn AL
Br J Vener Dis; 1983 Dec; 59(6):404-5. PubMed ID: 6196079
[TBL] [Abstract][Full Text] [Related]
15. The treatment of syphilis with salvarsan.
Dufty NE; Leverton D
J R Army Med Corps; 2014 Jun; 160 Suppl 1():i21-3. PubMed ID: 24845891
[No Abstract] [Full Text] [Related]
16. The original 'magic bullet' is 100 years old - extra.
Heynick F
Br J Psychiatry; 2009 Nov; 195(5):456. PubMed ID: 19880937
[No Abstract] [Full Text] [Related]
17. [Observations and criteria of syphilis therapy].
Krause H; Steinmann W
Z Hautkr; 1976 Dec; 51(24):1029-38. PubMed ID: 827131
[No Abstract] [Full Text] [Related]
18. [First results of treatment with salvarsan in Krakow].
Maciejasz B
Przegl Lek; 1996; 53(10):763-4. PubMed ID: 9091959
[TBL] [Abstract][Full Text] [Related]
19. Paul Ehrlich and 606.
Goldblatt D
Arch Neurol; 1986 Feb; 43(2):105. PubMed ID: 3947244
[No Abstract] [Full Text] [Related]
20. [The nature of arsenobenzene jaundice in syphilitics].
MARSHALL J
Prog Med (Paris); 1945; 73(19):310. PubMed ID: 20983997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
